Zaltrap Den Europæiske Union - dansk - EMA (European Medicines Agency)

zaltrap

sanofi winthrop industrie - aflibercept - kolorektale neoplasmer - antineoplastiske midler - behandling af metastatisk kolorektal cancer (mcrc).

Alofisel Den Europæiske Union - dansk - EMA (European Medicines Agency)

alofisel

takeda pharma a/s - darvadstrocel - rektal fistel - immunosuppressiva - alofisel er indiceret til behandling af komplekse endetarmsåbning fistler hos voksne patienter med ikke-aktive/mildt aktiv luminal crohn ' s sygdom, når fistler har vist et utilstrækkeligt respons på mindst én konventionelle eller biologiske terapi. alofisel bør anvendes efter konditionering af fistler.

Isemid Den Europæiske Union - dansk - EMA (European Medicines Agency)

isemid

ceva santé animale - torasemide - high-ceiling diuretics, sulfonamider, almindelig - hunde - til behandling af kliniske symptomer, der er relateret til kongestiv hjerteinsufficiens, i hunde, herunder lungeødem.

Hydrocortisone aceponate Ecuphar (previously Cortacare) Den Europæiske Union - dansk - EMA (European Medicines Agency)

hydrocortisone aceponate ecuphar (previously cortacare)

ecuphar - hydrocortisonacceponat - corticosteroider, dermatologiske præparater - hunde - til symptomatisk behandling af inflammatoriske og pruritiske dermatoser hos hunde. for alleviation of clinical signs associated with atopic dermatitis in dogs.

SmofKabiven Low Osmo Peripheral infusionsvæske, emulsion Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

smofkabiven low osmo peripheral infusionsvæske, emulsion

fresenius kabi ab - alanin, arginin, calciumchloriddihydrat, fiskeolie, rig på omega-3-syrer, glucosemonohydrat, glycin, histidin, isoleucin, kaliumchlorid, leucin, lysinacetat, magnesiumsulfatheptahydrat, methionin, natriumacetattrihydrat, natriumglycerophosphat, hydreret, olivenolie, renset, phenylalanin, prolin, serin, soyaolie, renset, taurin, threonin, triglycerider, middelkædelængde, tryptophan, tyrosin, valin, zinksulfat heptahydrat - infusionsvæske, emulsion

Daxocox Den Europæiske Union - dansk - EMA (European Medicines Agency)

daxocox

ecuphar nv - enflicoxib - antiinflammatoriske og antirheumatiske produkter - hunde - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

Cresnisol N24 infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

cresnisol n24 infusionsvæske, opløsning

baxter a/s - alanin, arginin, asparaginsyre, glutaminsyre, glycin, histidin, isoleucin, kaliumchlorid, leucin, lysinacetat, magnesiumchloridhexahydrat, methionin, natriumacetattrihydrat, natriumglycerophosphat, hydreret, phenylalanin, prolin, serin, threonin, tryptophan, tyrosin, valin - infusionsvæske, opløsning

PreHevbri Den Europæiske Union - dansk - EMA (European Medicines Agency)

prehevbri

vbi vaccines b.v. - hepatitis b overflade antigen - hepatitis b - vacciner - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

Zokinvy Den Europæiske Union - dansk - EMA (European Medicines Agency)

zokinvy

eigerbio europe limited - lonafarnib - progeria; laminopathies - andre alimentary tract and metabolism produkter, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.

Ebvallo Den Europæiske Union - dansk - EMA (European Medicines Agency)

ebvallo

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.